Navigation Links
All cancer cells are not created equal
Date:5/15/2012

erentiation revealed distinct populations of RMS cells in the zebrafish model. Cells expressing the progenitor cell marker myf5, were labeled green, and those expressing myogenin, a marker of mature muscle cells, were labeled red.

In a series of experiments, the research team confirmed that myf5-expressing RMS cells had powerful tumor-propagating potential, but the ability to visualize how tumor cells move in living fish produced a surprising observation. While myf5-expressing cells largely remained within the primary tumor itself, myogenin-expressing RMS cells easily moved out from the tumor, entering the vascular system and passing through usually impenetrable layers of collagen. Only after the more-differentiated but non-proliferative myogenin-expressing cells had colonized an area did the myf5-expressing tumor-propagating cells appear and start the growth a new tumor. Imaging the labeled tumor cells also revealed that different cellular populations tended to cluster in different areas of later-stage tumors.

"Our direct in-vivo imaging studies are the first to suggest such diverse cellular functions in solid tumors, based on differentiation and the propensity for self-renewal," says Myron Ignatius, PhD, of MGH Pathology and Center for Cancer Research, the study's first author. "I think we will find that this kind of division of labor is a common theme in cancer, especially given that the vast majority of cells within a tumor are not tumor-propagating cells. We suspect there will be molecularly defined populations that make niches for tumor-propagating cells, secrete factors to recruit vasculature and create boundaries to suppress immune cell invasion."

Langenau adds, "Division of labor is a new and emerging concept in cancer research that we hope will lead to new targets for rationally designed therapies. In rhabdomyosarcoma it will be important to target both the tumor-propagating cells and the highly migratory colonizing c
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. A marker in the lining of the lungs could be useful diagnostic technique for lung cancer screening
2. Video-assisted thoracic surgery valuable tool in lung cancer screening
3. Cancer vaccine combination therapy shows survival benefit in breast cancer
4. Study highlights need for coordination of care in stage 2 and 3 rectal cancer treatment
5. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
6. Study examines BI-RADS and MRI in predicting breast cancer
7. Early biomarker for pancreatic cancer identified
8. Fertilizing bone marrow helps answer why some cancers spread to bones
9. Genetic test identifies eye cancer tumors likely to spread
10. Scientists make breakthrough in bile duct cancer with discovery of new gene mutations
11. Drug kills cancer cells by restoring faulty tumor suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... ... Trenton Health Team has been certified by the New Jersey Department of Human ... serving the greater Trenton community. The ACO pilot is for a three-year period, ... structure of THT, bringing together the vast majority of Trenton’s primary and specialty care ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... Pharmacy’s premier event and tradeshow, taking place July 29 to August 1. Retail ... makers. , ThoughtSpot is a four-day event for independent community pharmacies, ...
(Date:6/30/2015)... ... 30, 2015 , ... The American Lung Association in California announced its new ... Diego. Speakers and clean air advocates included San Diego County Supervisor Ron Roberts, Dr. ... and Daniel Sullivan, founder and president of Sullivan Solar Power. , For every ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... titled, “University Post-Acute Rehab”. The video focuses on the rehab center’s patients and ... indicating it provides the best quality of services available. Each patient attests to ...
(Date:6/30/2015)... ... ... According to a June 15th report from USC News, a ... can be used to “decrease children’s anxiety and negative responses during oral care.” The ... patient experience in a “typical dental environment” with one that provides “visual, auditory and ...
Breaking Medicine News(10 mins):Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3
... June 6 (HealthDay News) -- Men who have type 2 ... from a regular exercise regimen, a new study has found. ... boost survival rates for men with both conditions, researchers found. ... which commonly occurs in people with diabetes and high blood ...
... A new poll by the Harvard School of Public Health ... the health care reform legislation enacted in 2006, 21% oppose ... heard or read about the law. The percentage of residents ... Support for the law varied by party affiliation, with 77% ...
... Hull have discovered a way to load up nanoparticles ... more effective form of photodynamic therapy (PDT) for treating ... light, cause irreparable damage to cells by creating toxic ... works with individual light-sensitive molecules but the new ...
... CHICAGO As the world marks the 30-year anniversary of ... a new challenge for people with the incurable disease. ... higher rate of cancers not usually associated with HIV. ... and neck, liver, kidney, and anal cancers, among others. ...
... A new targeted therapy for prostate cancer halts tumor ... resistant to hormone therapy, a new study finds. The ... 93rd Annual Meeting in Boston. "This targeted therapy ... lives of men with advanced, hormone-refractory prostate cancer," said ...
... Amanda Gardner HealthDay Reporter , SATURDAY, June 4 ... cancer drug, Avastin, may benefit both early stage ovarian cancer ... both studies, presented Saturday at the annual meeting of the ... added to standard chemotherapy. But the high cost ...
Cached Medicine News:Health News:Exercise Helps Men Battling Diabetes and Sleep Apnea 2Health News:Support for Massachusetts landmark health reform law rises in 2011 2Health News:Support for Massachusetts landmark health reform law rises in 2011 3Health News:Research creates nanoparticles perfectly formed to tackle cancer 2Health News:Many of those living with HIV face a new life-threatening challenge: cancer 2Health News:Many of those living with HIV face a new life-threatening challenge: cancer 3Health News:Targeted cancer therapy kills prostate tumor cells 2Health News:Cancer Drug Avastin Makes Inroads Against Ovarian Tumors 2Health News:Cancer Drug Avastin Makes Inroads Against Ovarian Tumors 3
(Date:6/30/2015)... ATLANTA , June 30, 2015 Legal-Bay ... the first bellwether trial in the multidistrict litigation (MDL) ... scheduled to begin October 13 th , 2015. There ... Inc. which have been consolidated before a federal judge ... that the first bellwether trial will begin in October ...
(Date:6/29/2015)... , June 29, 2015  Daktari Diagnostics was honored at ... Technology in the Service of Society Award. IEEE President and ... Barry L. Shoop presented the award to Principal Scientist ... ceremony was held Saturday, June 20, 2015, at the historic ... . "I have spent more than 3 ...
(Date:6/29/2015)... Minn. , June 29, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... it has commenced an underwritten public offering of units. ... stock, Series A warrants to purchase common stock and ... purchase of units in the offering would result in ...
Breaking Medicine Technology:Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3Daktari Honored with IEEE Spectrum Award 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... 5 P.M. EDT MONDAY, AUG. 4/, /ADVANCE/ ROCKVILLE, ... should not be,screened for prostate cancer, and younger men ... (PSA) test with their clinicians,before being tested, according to ... The recommendation and accompanying,evidence summary appear in the August ...
... 12 with 48-week boceprevir-based ... combination therapy ... KENILWORTH, N.J., Aug. 4 Schering-Plough,Corporation (NYSE: SGP ) today reported ... boceprevir, its investigational,oral hepatitis C protease inhibitor. The analysis showed a high ...
Cached Medicine Technology:Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 2Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: